Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2017 Mar 01;379:2485-2503. doi: 10.1523/JNEUROSCI.3070-16.2017.
Show Gene links
Show Anatomy links
Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human Cav2.1 (P/Q-Type) Calcium Channels.
Fu SJ, Jeng CJ, Ma CH, Peng YJ, Lee CM, Fang YC, Lee YC, Tang SC, Hu MC, Tang CY.
???displayArticle.abstract???
Voltage-gated CaV2.1 channels comprise a pore-forming α1A subunit with auxiliary α2δ and β subunits. CaV2.1 channels play an essential role in regulating synaptic signaling. Mutations in the human gene encoding the CaV2.1 subunit are associated with the cerebellar disease episodic ataxia type 2 (EA2). Several EA2-causing mutants exhibit impaired protein stability and exert dominant-negative suppression of CaV2.1 wild-type (WT) protein expression via aberrant proteasomal degradation. Here, we set out to delineate the protein degradation mechanism of human CaV2.1 subunit by identifying RNF138, an E3 ubiquitin ligase, as a novel CaV2.1-binding partner. In neurons, RNF138 and CaV2.1 coexist in the same protein complex and display notable subcellular colocalization at presynaptic and postsynaptic regions. Overexpression of RNF138 promotes polyubiquitination and accelerates protein turnover of CaV2.1. Disrupting endogenous RNF138 function with a mutant (RNF138-H36E) or shRNA infection significantly upregulates the CaV2.1 protein level and enhances CaV2.1 protein stability. Disrupting endogenous RNF138 function also effectively rescues the defective protein expression of EA2 mutants, as well as fully reversing EA2 mutant-induced excessive proteasomal degradation of CaV2.1 WT subunits. RNF138-H36E coexpression only partially restores the dominant-negative effect of EA2 mutants on CaV2.1 WT functional expression, which can be attributed to defective membrane trafficking of CaV2.1 WT in the presence of EA2 mutants. We propose that RNF138 plays a critical role in the homeostatic regulation of CaV2.1 protein level and functional expression and that RNF138 serves as the primary E3 ubiquitin ligase promoting EA2-associated aberrant degradation of human CaV2.1 subunits.SIGNIFICANCE STATEMENT Loss-of-function mutations in the human CaV2.1 subunit are linked to episodic ataxia type 2 (EA2), a dominantly inherited disease characterized by paroxysmal attacks of ataxia and nystagmus. EA2-causing mutants may exert dominant-negative effects on the CaV2.1 wild-type subunit via aberrant proteasomal degradation. The molecular nature of the CaV2.1 ubiquitin-proteasome degradation pathway is currently unknown. The present study reports the first identification of an E3 ubiquitin ligase for CaV2.1, RNF138. CaV2.1 protein stability is dynamically regulated by RNF138 and auxiliary α2δ and β subunits. We provide a proof of concept that protecting the human CaV2.1 subunit from excessive proteasomal degradation with specific interruption of endogenous RNF138 function may partially contribute to the future development of a novel therapeutic strategy for EA2 patients.
Abriel,
Ubiquitylation of ion channels.
2005, Pubmed
Abriel,
Ubiquitylation of ion channels.
2005,
Pubmed Adams,
Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies.
2009,
Pubmed Altier,
The Cavβ subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels.
2011,
Pubmed Baloh,
Episodic ataxias 1 and 2.
2012,
Pubmed
,
Xenbase Birault,
Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis.
2013,
Pubmed Bloom,
Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation.
2003,
Pubmed Cahill,
Coexpression of cloned alpha(1B), beta(2a), and alpha(2)/delta subunits produces non-inactivating calcium currents similar to those found in bovine chromaffin cells.
2000,
Pubmed
,
Xenbase Cantí,
The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of alpha2delta subunits is key to trafficking voltage-gated Ca2+ channels.
2005,
Pubmed Catterall,
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.
2005,
Pubmed Catterall,
Voltage-gated calcium channels.
2011,
Pubmed Catterall,
Structure and regulation of voltage-gated Ca2+ channels.
2000,
Pubmed Chen,
Formation of an endophilin-Ca2+ channel complex is critical for clathrin-mediated synaptic vesicle endocytosis.
2003,
Pubmed Claessen,
Protein quality control in the ER: balancing the ubiquitin checkbook.
2012,
Pubmed Dahimene,
A CaV2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant.
2016,
Pubmed Deshaies,
RING domain E3 ubiquitin ligases.
2009,
Pubmed Graves,
Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2.
2008,
Pubmed
,
Xenbase Greer,
The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
2010,
Pubmed Hebert,
In and out of the ER: protein folding, quality control, degradation, and related human diseases.
2007,
Pubmed Higley,
Calcium signaling in dendritic spines.
2012,
Pubmed Holderith,
Release probability of hippocampal glutamatergic terminals scales with the size of the active zone.
2012,
Pubmed Hoppa,
α2δ expression sets presynaptic calcium channel abundance and release probability.
2012,
Pubmed Jen,
Primary episodic ataxias: diagnosis, pathogenesis and treatment.
2007,
Pubmed Jen,
Clinical spectrum of episodic ataxia type 2.
2004,
Pubmed Jen,
Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission.
2001,
Pubmed Jeng,
Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2.
2006,
Pubmed
,
Xenbase Jeng,
Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels.
2008,
Pubmed
,
Xenbase Jouvenceau,
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel.
2001,
Pubmed Kaeser,
RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction.
2011,
Pubmed Kim,
Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.
2005,
Pubmed Kleiger,
Perilous journey: a tour of the ubiquitin-proteasome system.
2014,
Pubmed Koester,
Calcium dynamics associated with action potentials in single nerve terminals of pyramidal cells in layer 2/3 of the young rat neocortex.
2000,
Pubmed Kravtsova-Ivantsiv,
Non-canonical ubiquitin-based signals for proteasomal degradation.
2012,
Pubmed Kühnle,
Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.
2013,
Pubmed Kulik,
Immunocytochemical localization of the alpha 1A subunit of the P/Q-type calcium channel in the rat cerebellum.
2004,
Pubmed Lee,
Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1.
2002,
Pubmed Lineberry,
The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane.
2008,
Pubmed Lipscombe,
Control of neuronal voltage-gated calcium ion channels from RNA to protein.
2013,
Pubmed Long,
A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.
2012,
Pubmed Lukacs,
CFTR: folding, misfolding and correcting the ΔF508 conformational defect.
2012,
Pubmed Lussier,
Activity-dependent ubiquitination of the AMPA receptor subunit GluA2.
2011,
Pubmed Lussier,
Ubiquitin ligase RNF167 regulates AMPA receptor-mediated synaptic transmission.
2012,
Pubmed Mabb,
Triad3A regulates synaptic strength by ubiquitination of Arc.
2014,
Pubmed MacGurn,
Ubiquitin and membrane protein turnover: from cradle to grave.
2012,
Pubmed Mantuano,
Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.
2010,
Pubmed Mezghrani,
A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels.
2008,
Pubmed Nachbauer,
Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature.
2014,
Pubmed Obermair,
Differential targeting of the L-type Ca2+ channel alpha 1C (CaV1.2) to synaptic and extrasynaptic compartments in hippocampal neurons.
2004,
Pubmed Page,
The CaVβ Subunit Protects the I-II Loop of the Voltage-gated Calcium Channel CaV2.2 from Proteasomal Degradation but Not Oligoubiquitination.
2016,
Pubmed Page,
Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response.
2004,
Pubmed
,
Xenbase Page,
N terminus is key to the dominant negative suppression of Ca(V)2 calcium channels: implications for episodic ataxia type 2.
2010,
Pubmed
,
Xenbase Pietrobon,
CaV2.1 channelopathies.
2010,
Pubmed Pranke,
Biosynthesis of cystic fibrosis transmembrane conductance regulator.
2014,
Pubmed Raike,
Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits.
2007,
Pubmed Rajakulendran,
Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.
2012,
Pubmed Rose,
The first knockin mouse model of episodic ataxia type 2.
2014,
Pubmed Rotin,
Physiological functions of the HECT family of ubiquitin ligases.
2009,
Pubmed Sakurai,
Immunochemical identification and differential phosphorylation of alternatively spliced forms of the alpha 1A subunit of brain calcium channels.
1995,
Pubmed Sakurai,
Biochemical properties and subcellular distribution of the BI and rbA isoforms of alpha 1A subunits of brain calcium channels.
1996,
Pubmed Schwarz,
Activity-dependent ubiquitination of GluA1 mediates a distinct AMPA receptor endocytosis and sorting pathway.
2010,
Pubmed Sheng,
Calcium-channel number critically influences synaptic strength and plasticity at the active zone.
2012,
Pubmed Soong,
Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation.
2002,
Pubmed Tai,
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
2008,
Pubmed Tsai,
Ubiquitin proteasome system-mediated degradation of synaptic proteins: An update from the postsynaptic side.
2014,
Pubmed Vembar,
One step at a time: endoplasmic reticulum-associated degradation.
2008,
Pubmed Veneziano,
Dramatically different levels of Cacna1a gene expression between pre-weaning wild type and leaner mice.
2011,
Pubmed Volk,
Chemical and genetic strategies for manipulating polyubiquitin chain structure.
2005,
Pubmed Waithe,
Beta-subunits promote the expression of Ca(V)2.2 channels by reducing their proteasomal degradation.
2011,
Pubmed Wan,
Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2.
2011,
Pubmed Wappl,
Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia.
2002,
Pubmed
,
Xenbase Westenbroek,
Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels.
1995,
Pubmed Yamada,
NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF).
2006,
Pubmed
,
Xenbase Zhou,
A novel gene RNF138 expressed in human gliomas and its function in the glioma cell line U251.
2012,
Pubmed
